A review of published and grey literature and interviews with national experts in the partner countries will be used to (i) identify theoretical and applied financing and payment schemes, (ii) distinguish the financial incentives to treat multi-morbidity at micro (patient, provider), meso (organization), and macro (country) level, and (iii) produce a comprehensive description of the characteristics and requirements for different payment schemes to be appropriate for supporting ICC. Routine data from regional/national registries in the partner countries and a variety of program evaluation techniques will be used to estimate the impact of payments schemes on health care expenditures, quality of care, and efficiency at regional/national level. Interviews will be held with professionals in the projects selected in WP1 in order to investigate what financial incentives were applied and which methods were used for price-setting of ICC models.
Other partners involved: